"Real World" Difference in Effectiveness between Brand-Name and Generic Drugs - Real? or Fantasy?

被引:0
|
作者
Wu, Yih-Jer [1 ,2 ,3 ]
机构
[1] MacKay Mem Hosp, Ctr Cardiovasc, Dept Internal Med, Taipei, Taiwan
[2] MacKay Mem Hosp, Dept Med Educ, Taipei, Taiwan
[3] Mackay Med Coll, Dept Med, Taipei, Taiwan
关键词
D O I
10.6890/IJGE.201906_13(2).EC
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
引用
收藏
页码:105 / 105
页数:1
相关论文
共 50 条
  • [41] Comparative Effectiveness of Generic and Brand-Name Statins on Patient Outcomes A Cohort Study
    Gagne, Joshua J.
    Choudhry, Niteesh K.
    Kesselheim, Aaron S.
    Polinski, Jennifer M.
    Hutchins, David
    Matlin, Olga S.
    Brennan, Troyen A.
    Avorn, Jerry
    Shrank, William H.
    [J]. ANNALS OF INTERNAL MEDICINE, 2014, 161 (06) : 400 - U56
  • [42] Converting from brand-name to generic clozapine: A review of effectiveness and tolerability data
    Bobo, William V.
    Stovall, Jeffrey A.
    Knostman, Molly
    Koestner, Jim
    Shelton, Richard C.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (01) : 27 - 37
  • [43] Comparative Effectiveness of Generics and Brand-name Venlafaxine On Costs and Outcomes in the Real World Medical Care of Patients with Generalized Anxiety Disorder
    Sicras-Mainar, A.
    Rejas-Gutierrez, J.
    Ibanez-Nolla, J.
    Navarro-Artieda, R.
    [J]. EUROPEAN PSYCHIATRY, 2015, 30
  • [44] Bioequivalence and in vitro antimicrobial activity between generic and brand-name levofloxacin
    Sun, Hsin-Yun
    Liao, Hsiao-Wei
    Sheng, Meng-Huei
    Tai, Hui-Min
    Kuo, Ching-Hua
    Sheng, Wang-Huei
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2016, 85 (03) : 347 - 351
  • [45] COMPETITION BETWEEN BRAND-NAME AND GENERICS - ANALYSIS ON PRICING OF BRAND-NAME PHARMACEUTICAL
    Kong, Ying
    [J]. HEALTH ECONOMICS, 2009, 18 (05) : 591 - 606
  • [46] The population's perceptions of generic drugs compared to original brand-name drugs in Peruvian hospitals
    Mendoza-Chuctaya, Giuston
    Samir Cubas-Llalle, Wildor
    Mejia, Christian R.
    Emerson Chachaima-Mar, Jorge
    Montesinos-Segura, Renee
    Arce-Villalobos, Laura R.
    Carlos Mamani-Cruz, John
    [J]. CADERNOS DE SAUDE PUBLICA, 2019, 35 (10):
  • [47] Reasons for Switchback from Generic to Brand-Name Drugs in a Cohort of Patients Treated by Allopurinol
    Laroche, M. L.
    Crepin, S.
    Deysson, M.
    Merle, L.
    [J]. DRUG SAFETY, 2009, 32 (10) : 905 - 906
  • [48] Financial incentives and physicians' prescription decisions on the choice between brand-name and generic drugs: Evidence from Taiwan
    Liu, Ya-Ming
    Yang, Yea-Huei Kao
    Hsieh, Chee-Ruey
    [J]. JOURNAL OF HEALTH ECONOMICS, 2009, 28 (02) : 341 - 349
  • [49] Generic medications for you, but brand-name medications for me
    Keenum, Amy J.
    DeVoe, Jennifer E.
    Chisolm, Deena J.
    Wallace, Lorraine S.
    [J]. RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2012, 8 (06): : 574 - 578
  • [50] Brand-name drugs are not more effective than generic versions for treating cardiovascular disease
    Manns, Braden
    [J]. ANNALS OF INTERNAL MEDICINE, 2009, 150 (08)